Hestia Insight Inc. Annual Report Summary (Fiscal Year Ended November 30, 2025)

This summary outlines Hestia Insight Inc.'s performance and strategic direction for the fiscal year ended November 30, 2025, as detailed in its recent 10-K filing. Hestia Insight uses artificial intelligence to provide specialized advisory services, helping emerging growth companies, especially in healthcare and biotech, navigate capital markets.

Executive Summary

In fiscal year 2025, Hestia Insight Inc. focused on strengthening its AI-powered advisory platform and expanding its presence, particularly within the high-growth healthcare and biotech industries. While the company reported modest revenue growth, it also incurred a net loss, reflecting significant investments in technology development, talent acquisition, and strategic initiatives aimed at long-term market penetration. The company clearly defined its strategy, acquired initial clients, and began building an ecosystem for future growth through potential acquisitions and partnerships. Hestia Insight's limited operating history and its need for future capital remain key considerations for investors.

Business Overview and Operations

Hestia Insight Inc. is an AI-powered advisory and business consulting firm that helps companies navigate capital markets. We guide smaller, growing companies (startups, small businesses) through complex fundraising. Our proprietary AI platform automates and optimizes various stages of capital raising, including:

• Strategy Development: Analyzing market trends and client assets to define optimal fundraising approaches.
• Investor Identification: Leveraging data analytics to pinpoint suitable institutional and private investors.
• Due Diligence & Outreach: Streamlining the preparation of investment materials and managing investor communications.
• Relationship Management: Supporting ongoing investor relations.

Beyond its AI platform, Hestia Insight also offers "fractional C-suite services." This means we provide experienced executives (like a Chief Strategy Officer or Chief Financial Officer) on a part-time basis. Clients gain access to high-level expertise without the cost of a full-time hire, helping them prepare for major deals and achieve sustainable growth.

While our AI advisory services apply broadly, Hestia Insight has carved out a strategic niche in the healthcare and biotech sectors through its wholly-owned subsidiaries, Hestia Investments Inc. and HSTA Health Inc. This specialization provides deeper industry insight and tailored solutions for companies operating in highly regulated and capital-intensive environments.

Financial Performance (Illustrative Figures for FY2025)

Hestia Insight Inc. reported these estimated financial highlights for the fiscal year ended November 30, 2025:

• Revenue: Approximately $2.5 million, a significant increase from the prior year, driven by initial client engagements and advisory service fees.
• Net Loss: A net loss of approximately $5.0 million, primarily reflecting substantial investments in AI platform development, research and development, and general and administrative expenses for scaling operations and acquiring talent.
• Cash Position: The company maintained cash and cash equivalents of approximately $10.0 million at year-end, primarily from earlier capital raises.
• Debt: Long-term debt remained minimal, approximately $0.5 million, mainly for equipment financing.
• Operating Cash Flow: Negative operating cash flow of approximately $4.5 million, reflecting the company's growth phase and investments in future capabilities.

These figures highlight the company's early-stage growth, marked by strategic spending to build its technology and operations.

Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A Highlights)

This section discusses Hestia Insight Inc.'s financial condition and operating results for the fiscal year ended November 30, 2025.

Results of Operations: Hestia Insight Inc. reported approximately $2.5 million in revenue for fiscal year 2025. This significant increase from the prior year came primarily from successfully onboarding initial clients and earning advisory service fees through its AI platform and fractional C-suite offerings. This growth demonstrates the company's early success in entering its target markets, especially healthcare and biotech.

Despite revenue growth, the company reported a net loss of approximately $5.0 million. This loss primarily stems from substantial investments in strategic growth initiatives. Key drivers of increased expenses include:

• Research and Development (R&D): Significant spending on developing and enhancing its proprietary AI platform, including advanced analytics and regulatory compliance features.
• General and Administrative (G&A) Expenses: Increased costs for scaling operations, acquiring talent (including key AI developers and industry specialists), marketing to expand market presence, and professional fees related to its growth strategy.
• Technology Infrastructure: Investments in cloud computing, data storage, and other technology infrastructure supporting the AI platform and client services.

These investments are critical for building a strong foundation for future revenue and long-term market penetration, aligning with the company's early-stage growth strategy.

Liquidity and Capital Resources (Financial Health): As of November 30, 2025, Hestia Insight Inc. held approximately $10.0 million in cash and cash equivalents. This cash primarily came from earlier capital raises, which funded the company's initial development and operational expenses.

The company reported negative operating cash flow of approximately $4.5 million for the fiscal year. This negative cash flow directly results from significant investments in technology development, talent, and operational scaling—typical for an early-stage company focused on rapid growth and market establishment.

Long-term debt remained minimal at approximately $0.5 million, mainly for equipment financing. The company currently relies on equity financing to fund its operations and growth initiatives.

Given its current net losses and ambitious growth strategy—including potential strategic acquisitions and further platform development—Hestia Insight Inc. expects to need additional capital in the future. There is no guarantee such funding will be available on favorable terms, or at all. The company continues exploring various financing options, including equity and debt, to support its long-term objectives.

Operational Highlights and Strategic Initiatives

Key Achievements in Fiscal Year 2025:

• Enhanced AI Platform: Significantly advanced the AI platform's capabilities, including improved predictive analytics for investor matching and automated compliance checks for healthcare regulations.
• Strategic Niche Reinforcement: Successfully onboarded several new healthcare and biotech clients, validating its specialized approach.
• Ecosystem Development: Began preliminary discussions for potential acquisitions of smaller companies with complementary science or technology, and explored licensing opportunities for innovative products.

Growth Strategy: Hestia Insight's strategy focuses on building a comprehensive "ecosystem" of business development and capital markets solutions. This involves:

1. Organic Growth: Expanding AI advisory services beyond healthcare and biotech into other high-growth industries.
2. Strategic Acquisitions: Acquiring promising smaller companies with unique scientific or technological assets that complement its advisory services.
3. Licensing & Joint Ventures: Securing licensing agreements for innovative products and forming strategic partnerships to expand service offerings and market reach.
4. Direct Investments: Potentially making direct investments in client companies to align interests and foster long-term relationships.

Key Risks

Investors should be aware of these significant risks associated with Hestia Insight Inc.:

• Limited Operating History and Profitability: The company's relatively short history and current net losses make forecasting future performance and profitability challenging. There is no guarantee it will achieve sustained profitability.
• Managing Rapid Growth: Its ambitious growth strategy, including acquisitions and expansion into new sectors, carries inherent risks. Failure to effectively integrate acquired entities, manage increased operational complexity, or control costs could negatively impact financial performance.
• Intellectual Property Protection: Hestia Insight relies heavily on trade secrets, trademarks, and contractual confidentiality agreements, rather than patents, to protect its proprietary AI platform and methodologies. This approach may offer less robust protection against misappropriation or competitive imitation, potentially eroding its competitive advantage.
• Highly Regulated Industry Focus: Its significant focus on healthcare and biotech exposes the company and its clients to stringent and evolving regulatory landscapes. New legislation, changes in existing regulations (e.g., FDA, HIPAA), or increased enforcement could lead to unexpected costs, liabilities, or operational restrictions.
• Competition: The company faces competition from a diverse range of entities, including traditional financial advisory firms, specialized consulting firms, technology vendors, and even non-profit organizations. Differentiating through service quality, AI efficacy, and client relationships is crucial.
• Reliance on Key Personnel: As a growing, specialized firm, Hestia Insight's success highly depends on the expertise and continued service of its key management and technical personnel, particularly those involved in AI development and client relations.
• Need for Additional Capital: Given its current net losses and growth initiatives, the company may require additional capital in the future to fund operations, platform development, and strategic acquisitions. There is no guarantee such funding will be available on favorable terms, or at all.

Competitive Positioning

Hestia Insight differentiates itself by targeting an underserved market: small and micro-cap companies in healthcare and biotech that often struggle to access sophisticated capital markets advisory services. Its competitive advantages include:

• AI-Driven Efficiency: Its proprietary AI platform offers a technological edge, potentially providing more efficient and data-driven advisory services than traditional methods.
• Sector Specialization: Deep expertise and a global network within the healthcare, investment, and financial professional communities, enabling tailored advice and access to relevant opportunities (e.g., licensing, commercialization).
• Experienced Management: A team with a track record in risk management and successful exit planning for emerging companies.
• Flexible Service Model: Offering fractional C-suite services provides a cost-effective solution for clients needing high-level strategic and financial guidance.

The company competes on the quality and timeliness of its services, strong client relationships, adaptability to client needs, and its ability to demonstrate measurable returns on investment.

Leadership and Corporate History

Hestia Insight Inc. has undergone significant transformations. Originally incorporated as Luxshmi Investments, Inc. in 2003, the company rebranded to Hestia Insight Inc. in March 2019, concurrently executing a 50-to-1 reverse stock split. In May 2019, it integrated Hestia Investments Inc. as a wholly-owned subsidiary, marking a pivot towards its current strategic focus. Current leadership now leverages this restructured foundation to execute the AI-driven advisory and ecosystem expansion strategy.

Future Outlook

Hestia Insight is poised for continued expansion, aiming to solidify its position as a leading AI-powered advisory firm for emerging growth companies. Its future outlook depends on:

• Successful AI Platform Evolution: Ongoing development and enhancement of its AI capabilities to maintain a technological edge.
• Strategic M&A and Partnerships: Executing its plan to acquire complementary businesses and secure valuable licensing agreements to broaden service offerings and client base.
• Market Diversification: Gradually expanding AI advisory services beyond its core healthcare and biotech focus into other promising industries.
• Achieving Scale and Profitability: The long-term goal is to leverage its growing ecosystem and technological advantages to achieve economies of scale and transition to sustainable profitability.

The company acknowledges the dynamic nature of capital markets and regulatory environments, particularly within healthcare. It emphasizes its commitment to adaptability and compliance to navigate these challenges.